SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-17-000102
Filing Date
2017-08-21
Accepted
2017-08-21 09:49:53
Documents
4
Period of Report
2017-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K a8k-drgray.htm 8-K 54602
2 EXHIBIT 99.1 ligandappointsdrnancygra.htm EX-99.1 5358
3 ligandappointsdrnancygra001.jpg GRAPHIC 210304
4 ligandappointsdrnancygra002.jpg GRAPHIC 48063
  Complete submission text file 0000886163-17-000102.txt   411946
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 171042275
SIC: 2834 Pharmaceutical Preparations